The Roku 3 television streaming player menu is shown on a television in Los Angeles, California, U.S., on Thursday, Sept. 12, 2013. Patrick T. Fallon | Bloomberg via Getty Images Check out the companies making headlines after the bell:  Roku — Shares of video-streaming company dropped 12% in extended trading after the firm’s fourth-quarter revenue missed
0 Comments
When I saw InvestorPlace’s Chris Tyler’s take on Digital World Acquisition (NASDAQ:DWAC), the special purpose acquisition company poised to take Trump Media & Technology Group (TMTG) public, I found myself conflicted. In any other circumstance, I would agree wholeheartedly with his position on DWAC stock. Source: rafapress / Shutterstock And that position is simply this:
0 Comments
A little more than a year ago, I discussed whether Opendoor Technologies (NASDAQ:OPEN) and OPEN stock was a better buy than Zillow (NASDAQ:Z, NASDAQ:ZG). I concluded that, until Opendoor got its business back to pre-Covid numbers, Zillow was the safer bet. Source: Tada Images / Shutterstock.com As we know in hindsight, the entire home-buying business
0 Comments
Based on the recent headlines about Digital World Acquisition (NASDAQ:DWAC) stock, you would think that it was about to plunge. However, DWAC stock has stayed strong. Source: rafapress / Shutterstock The shares closed yesterday at $85.16 per share, or eight times its offering price. As you likely know, this SPAC is taking former President Donald Trump’s
0 Comments
Vanguard funds, including exchange-traded funds (ETFs) and mutual funds, allow investors to obtain exposure to equity and bond markets at reasonable costs with highly competitive expense ratios in the fund industry. Vanguard funds typically come with no load fees, and many are available free of transaction fees through numerous investment broker platforms. The Morningstar rating
0 Comments
At first glance, Michigan-based veterinary testing and pharmaceutical product specialist Zomedica (NYSEAMERICAN:ZOM) might sound like a great company to invest in. After all, ZOM stock is really cheap, and pet healthcare certainly sounds like a high-growth niche market. Source: Postmodern Studio / Shutterstock.com On the other hand, we have to wonder why Zomedica’s shares are so
0 Comments